Type and Timing of Reversal Agents in Patients Receiving Warfarin Who are Hospitalized for Major Bleeding

Background: In patients with warfarin-induced major bleeding, prompt administration of reversal agents increases coagulation factors and may allow early surgical correction of bleeding. However even with reversal agents, mortality is high. In this analysis the type and timing of reversal agents were evaluated.

Methods: Review of warfarin treated non-trauma patients admitted to a University Hospital with ISTH defined major bleeding between October 2009 and January 2013.

Results: 84 patients met entry criteria with a mean age 67.8 ± 14.3 years including 46 % females. The mean INR on admission was 3.6 ± 2.4. The site of major bleeding was central nervous system in 33 (39%), abdomen in 28 (33%), chest in 6 (7%) and other in 15 (18 %). Reversal agents including vitamin K, fresh frozen plasma (FFP), or prothrombin complex concentrate (PCC) were given to 83 patients. Forty patients required either major surgery (25 patients) or a therapeutic procedure (14 patients) to stop bleeding. Death occurred in 15 patients (18%) but the admission INR was not predictive of mortality (p=0.52, Kruskal-Wallis test). The INR was never completely corrected (INR<1.1) in 31 (37%) patients, 9 of whom died.

Conclusions: Patients with warfarin-induced major bleeding receive ineffective anticoagulation reversal, have delayed times to therapeutic procedures, and have a high mortality rate. Whether earlier administration of these agents or administration of newer agents would reduce hospital mortality requires further study.

Full Article: HERE

Go through the Journal: http://www.enlivenarchive.org/clinical-cardiology-and-research/

Contact Us: http://www.enlivenarchive.org/contact.php

 

Gender-Related Differences in Risk Profile in Young Patients with St-Elevation Myocardial Infarction a 7-Year Single Centre Experience

Few studies have focused on acute ST-elevation myocardial infarction (STEMI) in young patients. We aimed to analyze the incidence, risk factors, management, and prognosis of STEMI in 182 consecutive young patients (age < /= 50 years) (2004 to 2012), focusing on gender-related differences.

Males (87.4%) showed higher BMI values (p=0.004), a higher incidence of overweight and obesity (p=0.016). Diabetes was more frequent in females (p=0.02).

The main findings of your investigation are as follows: a) over the 7 year-study period the percentage of young STEMI patients did not change; b) the risk profile of males was different from that of females who showed a higher incidence of diabetes, while the frequency of smoking and hypertension was comparable between the two subgroups; c) no gender-related difference was detectable in management also in regard to medical therapy at discharge; d) young STEMI patients showed a good prognosis at short and long term.

Follow the Full length Article HERE

Contact us at: cardiology@enlivenarchive.org

Journal Website: http://www.enlivenarchive.org/clinical-cardiology-and-research/